Modelling uncertainty in survival and cost-effectiveness is vital in the era of gene therapies: the case of axicabtagene ciloleucel.

Details

Language :

English

ISSN :

22118837

Volume :

8

Issue :

2

Database :

Complementary Index

Journal :

Health Policy & Technology

Publication Type :

Academic Journal

Accession number :

136803232

Full Text :

https://doi.org/10.1016/j.hlpt.2019.05.009